Amicrobe Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.48M
Latest Deal Amount
  • Investors
  • 2

Amicrobe General Information

Description

Developer of advanced biomaterials designed to prevent and treat life-threatening infections. The company's antimicrobial products are long-chain amino acid block copolymers, broadly antimicrobial against gram-positive and gram-negative bacteria including antibiotic-resistant strains, as well as yeast, enabling medical care professionals to prevent infection during surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 3142 Tiger Run Court
  • Suite 101
  • Carlsbad, CA 92010
  • United States
+1 (888) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amicrobe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 24-Oct-2017 $2.48M 000 Completed Generating Revenue
3. Later Stage VC (Series C) 18-Sep-2013 000 000 0000 Completed Generating Revenue
2. Grant 01-Jan-2012 $161K $1000K Completed Generating Revenue
1. Early Stage VC 18-Feb-2011 $1000K $1000K 0000 Completed Generating Revenue
To view Amicrobe’s complete valuation and funding history, request access »

Amicrobe Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 000,000 00.000000 00.00 00.00 0000 0000 00.00 00.000
Series A 800,000 $0.000100 $0 $0.01 $0.01 1x $0.05 1.63%
To view Amicrobe’s complete cap table history, request access »

Amicrobe Executive Team (7)

Name Title Board Seat Contact Info
Michael Bevilacqua MD Co-Founder, Chief Executive Officer, Chief Strategy Officer & Board Member
Timothy Deming Ph.D Co-Founder & Head of SAB
Carl Edwards Ph.D Head, Preclinical Research and Development
Daniel Huang Vice President, Operations
Joseph Solomkin MD Chief Medical Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Amicrobe Board Members (4)

Name Representing Role Since
Alan Mendelson ESQ Self Secretary, Board Member and Corporate Council 000 0000
Albert Carnesale Ph.D Amicrobe Board Member 000 0000
Michael Flesch Self Chairman 000 0000
To view Amicrobe’s complete board members history, request access »

Amicrobe Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CARB-X Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Amicrobe’s complete investors history, request access »